How to Avoid Patent Cliffs: Product Hopping in the Pharma Sector

In May 2015, Mylan Pharmaceuticals appealed to the Third Circuit after the lower court dismissed its case against … Continue Reading

US v. EU: Pay-for-delay Settlements

Reverse payment settlements exist at the intersection among antitrust, patent and healthcare laws. Also known as pay-for-delay agreements, these … Continue Reading